Biomarkers for pain: See related article by Eisenach et al., pages 207-212 of this issue

Pain

Volumn 107, Issue 3, 2004, Pages 199-201

  Kalso, Eija ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; CYSTATIN;

EDITORIAL; GENETIC CODE; HUMAN; IMMUNOMODULATION; INFLAMMATION; KIDNEY FUNCTION; PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TISSUE INJURY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; METABOLISM; NOTE;

BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CYSTATINS; HUMANS; PAIN;

EID: 1842452956     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.12.009     Document Type: Editorial

References (19)

1. Abrahamson M., Olafsson I., Palsdottir A., Ulvsback M., Lundwall A., Jensson O., Grubb A. Structure and expression of the human cystatin C gene. Biochem J. 268:1990;287-294.
2. Afonso S., Romagnano L., Babiarz B. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development. 124:1997;3415-3425.
3. Barrett A.J., Fritz H., Grubb A., Isemura S., Jarvinen M., Katunuma N., Machleidt W., Muller-Esterl W., Sasaki M., Turk V. Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J. 236:1986;312.
4. Bollengier F. Cystatin C alias post-γ-globulin: a marker for multiple sclerosis? J Clin Chem Clin Biochem. 25:1987;589-593.
5. Coulibaly S., Schwihla H., Abrahamson M., Albini A., Cerni C., Clark J.L., Ng K.M., Katunuma N., Schlappack O., Glossl J., Mach L. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer. 83:1999;526-531.
6. Cox J.L., Sexton P.S., Green T.J., Darmani N.A. Inhibition of B16 melanoma metastasis by overexpression of the cysteine protease inhibitor cystatin C. Melanoma Res. 9:1999;369-374.
7. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
8. Ishimaru H., Ishikawa K., Ohe Y., Takahashi A., Maruyama Y. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus. Brain Res. 709:1996;155-162.
9. Lerner U.H., Grubb A. Human cystatin C, a cysteine protease inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J Bone Miner Res. 7:1992;433-440.
10. Levy E., Sastre M., Kumar A., Gallo G., Piccardo P., Ghetti B., Tagliavini F. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol. 60:2001;94-104.
11. 2- microglobulin at various ages and in neurological disorders. J Neurol. 223:1980;159-170.
12. Mannes A.J., Martin B.M., Yang H.-Y.T., Keller J.M., Lewin S., Gaiser R.R., Iadarola M.J. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain. 102:2003;251-256.
13. Nagai A., Murakawa Y., Tereshima M., Shimode K., Umegae N., Takeuchi H., Kobayashi S. Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology. 55:2000;1828-1832.
14. Shimizu-Tokiwa A., Kobata M., Io H., Kobayashi N., Shou I., Funabiki K., Fukui M., Horikoshi S., Shirato I., Saito K., Tomino Y. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron. 92:2002;224-226.
15. Taupin P, Ray J, Fisher WH, Suhr ST, Hakanson K, Grubb A, Gage FH. FGH-2-responsive neural stem cell proliferation requires CCg, a neural autocrine/paracrine cofactor. Neuron 2000;28:385 - 97.
16. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V., Kalso E., States B., Panula P., Ziff E. Gene for pain modulatory neuropeptide FF: induction in spinal cord by noxious stimuli. Mol Pharmacol. 55:1999;804-811.
17. Vray B., Hartmann S., Hoebeke J. Immunomodulatory properties of cystatins. Cell Mol Life Sci. 59:2002;1503-1512.
18. Yang H.-Y.T., Wilkening S., Iadarola M.J. Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience. 103:2001;493-502.
19. Yasuhara O., Hanai K., Ohkubo I., Sasaki M., McGeer P.L., Kimura H. Expression of cystatin C in rat, monkey and human brains. Brain Res. 628:1993;85-92.